Decoding frontotemporal and cell-type-specific vulnerabilities to neuropsychiatric disorders and psychoactive drugs

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Frontotemporal lobe (FL) abnormalities are linked to neuropsychiatric disorders.
• Cellular heterogeneity between temporal lobe (TL) and frontal lobe (FL) may influence vulnerability to genetic risk factors.
• The specific roles of these regional differences in cell vulnerability are not well understood.

Purpose of the Study:

• To investigate the impact of cellular heterogeneity between TL and FL on cell vulnerability to genetic risk factors and psychoactive drugs.
• To map cell-type-specific vulnerabilities in the context of neuropsychiatric disorders.
• To understand how brain regional differences influence genetic susceptibility and drug response.

Main Methods:

• Single-nucleus transcriptome analysis of fresh human FL and TL tissue.
• Integration of genetic susceptibility data, gene dysregulation in neuropsychiatric diseases, and psychoactive drug response data.
• Cell type and regional vulnerability analysis.

Main Results:

• Intrinsic differences between TL and FL contribute to the vulnerability of specific cell types.
• PVALB neurons are highly vulnerable to genetic risk factors for psychiatric diseases.
• Genes like GRIN2A and SLC12A5, associated with schizophrenia and bipolar disorder, are upregulated in TL PVALB neurons and in patient brains.
• TL PVALB neurons show twofold greater vulnerability to psychoactive drugs than to genetic risk factors.

Conclusions:

• Brain regional differences, specifically between TL and FL, significantly influence cell type vulnerabilities in neuropsychiatric disorders.
• PVALB neurons represent a key cell type vulnerable to genetic and pharmacological challenges in psychiatric conditions.
• This study provides a cell-type-resolved map of regional vulnerabilities relevant to neuropsychiatric disease.